| scholarly article | Q13442814 |
| P356 | DOI | 10.3389/FPHAR.2012.00066 |
| P8608 | Fatcat ID | release_h4fkkwreonfflbh4v7j62vsgpq |
| P932 | PMC publication ID | 3329863 |
| P698 | PubMed publication ID | 22529814 |
| P5875 | ResearchGate publication ID | 224821957 |
| P2093 | author name string | Brian N Mathur | |
| David M Lovinger | |||
| P2860 | cites work | LTP and LTD | Q22337342 |
| Neurotensin reduces glutamatergic transmission in the dorsolateral striatum via retrograde endocannabinoid signaling | Q24644749 | ||
| Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. | Q24648260 | ||
| Addiction, dopamine, and the molecular mechanisms of memory | Q28142501 | ||
| Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons | Q28144567 | ||
| Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity | Q28185479 | ||
| Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum. | Q48631827 | ||
| The electrophysiology of dopamine (D2) receptors: a study of the actions of dopamine on corticostriatal transmission | Q48736720 | ||
| Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization | Q48918978 | ||
| Both A1 and A2a purine receptors regulate striatal acetylcholine release | Q48940242 | ||
| 5-HT(1A) receptor stimulation and L-DOPA-induced dyskinesia in Parkinson's disease: bridging the gap between serotonergic and glutamatergic mechanisms | Q48961091 | ||
| Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease | Q49069694 | ||
| Associative short-term synaptic plasticity mediated by endocannabinoids | Q49076729 | ||
| Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. | Q52030475 | ||
| Key modulatory role of presynaptic adenosine A2A receptors in cortical neurotransmission to the striatal direct pathway. | Q54707901 | ||
| Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. | Q55487809 | ||
| The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D2/A2A Receptor Interaction in the Striatum: Implications for Parkinson's Disease | Q60715991 | ||
| Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age | Q69262673 | ||
| Presynaptic D2 dopaminergic receptors mediate inhibition of excitatory synaptic transmission in rat neostriatum | Q70822044 | ||
| Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes | Q72398870 | ||
| Short- and long-term synaptic depression in rat neostriatum | Q72665515 | ||
| Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats | Q72724643 | ||
| Dopamine selects glutamatergic inputs to neostriatal neurons | Q73042964 | ||
| Adenosine receptor expression and modulation of Ca(2+) channels in rat striatal cholinergic interneurons | Q73352680 | ||
| Long-term depression of cortico-striatal synaptic transmission by DHPG depends on endocannabinoid release and nitric oxide synthesis | Q81295058 | ||
| Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. | Q48452719 | ||
| Analysis of the effects of cannabinoids on identified synaptic connections in the caudate-putamen by paired recordings in transgenic mice | Q48477201 | ||
| A Requirement for the Intercellular Messenger Nitric Oxide in Long-Term Potentiation | Q48611776 | ||
| Decreased frequency but not amplitude of quantal synaptic responses associated with expression of corticostriatal long-term depression | Q48617011 | ||
| Structure of a cannabinoid receptor and functional expression of the cloned cDNA | Q28240076 | ||
| Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors | Q28292914 | ||
| The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1) | Q28343961 | ||
| Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons | Q28363375 | ||
| Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide | Q28370516 | ||
| Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors | Q28512698 | ||
| Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 | ||
| Formation and inactivation of endogenous cannabinoid anandamide in central neurons | Q29620558 | ||
| Dichotomous dopaminergic control of striatal synaptic plasticity | Q30493521 | ||
| Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function | Q30499670 | ||
| RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits | Q30504550 | ||
| Start/stop signals emerge in nigrostriatal circuits during sequence learning | Q30525757 | ||
| CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum | Q31817073 | ||
| Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses | Q33940688 | ||
| Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H2O2, and KATP channels | Q33996977 | ||
| Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens | Q34032832 | ||
| Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. | Q34521936 | ||
| Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling | Q34650334 | ||
| Dopamine-dependent synaptic plasticity in striatum during in vivo development | Q34658296 | ||
| Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine | Q34692213 | ||
| Serotonin induces long-term depression at corticostriatal synapses | Q35040674 | ||
| Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments | Q35208420 | ||
| Adenosine A2a receptor antagonists attenuate striatal adaptations following dopamine depletion. | Q35607243 | ||
| Plastic control of striatal glutamatergic transmission by ensemble actions of several neurotransmitters and targets for drugs of abuse | Q35611030 | ||
| Endocannabinoid signaling and long-term synaptic plasticity. | Q35679432 | ||
| Roles of the M1 muscarinic acetylcholine receptor subtype in the regulation of basal ganglia function and implications for the treatment of Parkinson's disease. | Q35776844 | ||
| Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves | Q35874165 | ||
| Coactivation of D1 and D2 dopamine receptors: in marriage, a case of his, hers, and theirs | Q35923169 | ||
| Decreased probability of neurotransmitter release underlies striatal long-term depression and postnatal development of corticostriatal synapses | Q36054269 | ||
| Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonism | Q36763909 | ||
| Interneuron activity controls endocannabinoid-mediated presynaptic plasticity through calcineurin | Q36786835 | ||
| Pharmacotherapy for Parkinson's disease. | Q37016031 | ||
| Presynaptic modulation by endocannabinoids | Q37026723 | ||
| Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity | Q37140712 | ||
| Striatal plasticity and basal ganglia circuit function | Q37336143 | ||
| Endocannabinoid-mediated control of synaptic transmission | Q37363621 | ||
| Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia. | Q39801798 | ||
| Multiple pathways involved in the biosynthesis of anandamide | Q40106992 | ||
| Genetic deletion of A2A adenosine receptors in the striatum selectively impairs habit formation | Q40303608 | ||
| Nitric oxide and hippocampal synaptic plasticity | Q40489978 | ||
| Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal | Q40552669 | ||
| Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat | Q41485453 | ||
| Endocannabinoid signaling is critical for habit formation | Q41978739 | ||
| Endocannabinoid-mediated short-term suppression of excitatory synaptic transmission to medium spiny neurons in the striatum | Q42167436 | ||
| Long-term synaptic depression in the striatum: physiological and pharmacological characterization | Q42453585 | ||
| Dopamine modulates release from corticostriatal terminals. | Q42469821 | ||
| Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia. | Q42477740 | ||
| Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission. | Q42479637 | ||
| Serotonin innervation of human basal ganglia | Q42484813 | ||
| Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia | Q42486484 | ||
| Tonic enhancement of endocannabinoid-mediated retrograde suppression of inhibition by cholinergic interneuron activity in the striatum. | Q42507026 | ||
| Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 | ||
| Role of tonically active neurons in primate caudate in reward-oriented saccadic eye movement. | Q42510486 | ||
| Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice | Q42513638 | ||
| Frequency-dependent inversion of net striatal output by endocannabinoid-dependent plasticity at different synaptic inputs | Q42555774 | ||
| Adenylyl cyclase type 5 contributes to corticostriatal plasticity and striatum-dependent learning | Q42668061 | ||
| Selective involvement of mGlu1 receptors in corticostriatal LTD. | Q43621325 | ||
| Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. | Q43816494 | ||
| Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: motor behavior and monoamine alterations at adult stage | Q43835685 | ||
| Postsynaptic endocannabinoid release is critical to long-term depression in the striatum | Q43971441 | ||
| Catalepsy induced by intrastriatal injections of Δ9-THC and 11-OH-Δ9-THC in the rat | Q44293969 | ||
| Cortico-striatal synaptic plasticity in endothelial nitric oxide synthase deficient mice | Q44306274 | ||
| Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus. | Q44334367 | ||
| The nitric oxide-guanylyl cyclase signaling pathway modulates membrane activity States and electrophysiological properties of striatal medium spiny neurons recorded in vivo. | Q44777528 | ||
| A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission | Q44853701 | ||
| Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals | Q44905912 | ||
| Induction of striatal long-term synaptic depression by moderate frequency activation of cortical afferents in rat. | Q45119266 | ||
| Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. | Q46279749 | ||
| Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain | Q46547524 | ||
| Feed-forward excitation of striatal neuron activity by frontal cortical activation of nitric oxide signaling in vivo | Q46678905 | ||
| Excitatory effects of serotonin on rat striatal cholinergic interneurones | Q46790371 | ||
| Depression of excitatory synaptic input in rat striatal neurons | Q46844616 | ||
| Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. | Q46896175 | ||
| Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission | Q46986845 | ||
| Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease. | Q48114419 | ||
| Role of the cyclic-AMP/PKA cascade and of P/Q-type Ca++ channels in endocannabinoid-mediated long-term depression in the nucleus accumbens. | Q48118951 | ||
| Combined activation of L-type Ca2+ channels and synaptic transmission is sufficient to induce striatal long-term depression. | Q48130770 | ||
| Glutamate-triggered events inducing corticostriatal long-term depression. | Q48162644 | ||
| Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats | Q48192232 | ||
| Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. | Q48217036 | ||
| The subcellular distribution of [3H]-CGS 21680 binding sites in the rat striatum: copurification with cholinergic nerve terminals | Q48237547 | ||
| Anandamide regulates postnatal development of long-term synaptic plasticity in the rat dorsolateral striatum. | Q48257640 | ||
| Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors. | Q48319536 | ||
| Depolarization-induced suppression of inhibition mediated by endocannabinoids at synapses from fast-spiking interneurons to medium spiny neurons in the striatum | Q48396596 | ||
| Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction | Q48406779 | ||
| P921 | main subject | striatum | Q1319792 |
| synaptic plasticity | Q1551556 | ||
| endocannabinoids | Q10483908 | ||
| P304 | page(s) | 66 | |
| P577 | publication date | 2012-04-19 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | Endocannabinoid-dopamine interactions in striatal synaptic plasticity | |
| P478 | volume | 3 |
| Q47095276 | Adenosine A1-A2A Receptor Heteromer as a Possible Target for Early-Onset Parkinson's Disease |
| Q38949527 | Asymmetric dopaminergic degeneration and levodopa alter functional corticostriatal connectivity bilaterally in experimental parkinsonism |
| Q50055065 | Bidirectional and long-lasting control of alcohol-seeking behavior by corticostriatal LTP and LTD. |
| Q91046020 | Cannabinoid CB1 receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior |
| Q34451442 | Cannabinoid modulation of drug reward and the implications of marijuana legalization |
| Q61805140 | Compensatory Relearning Following Stroke: Cellular and Plasticity Mechanisms in Rodents |
| Q38234309 | Direct and indirect pathways of basal ganglia: a critical reappraisal |
| Q57295457 | Dopamine-endocannabinoid interactions mediate spike-timing-dependent potentiation in the striatum |
| Q38233462 | Dopaminergic modulation of striatal networks in health and Parkinson's disease |
| Q47319226 | Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens |
| Q28551031 | Endocannabinoid dynamics gate spike-timing dependent depression and potentiation |
| Q36300201 | Endocannabinoid signaling mediates oxytocin-driven social reward |
| Q48085620 | Endocannabinoids mediate bidirectional striatal spike-timing-dependent plasticity |
| Q30573767 | Functional dynamics of primate cortico-striatal networks during volitional movements |
| Q36894496 | Genome-Wide DNA Methylation Profiling Reveals Epigenetic Changes in the Rat Nucleus Accumbens Associated With Cross-Generational Effects of Adolescent THC Exposure |
| Q36019618 | Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder. |
| Q38976397 | Insights About Striatal Circuit Function and Schizophrenia From a Mouse Model of Dopamine D2 Receptor Upregulation |
| Q41412530 | Interneuronal Nitric Oxide Signaling Mediates Post-synaptic Long-Term Depression of Striatal Glutamatergic Synapses. |
| Q48309451 | Long-Term Plasticity in Amygdala Circuits: Implication of CB1-Dependent LTD in Stress |
| Q59477201 | Medical treatment of dystonia |
| Q90296841 | Modulation of Spike-Timing Dependent Plasticity: Towards the Inclusion of a Third Factor in Computational Models |
| Q47316451 | Nucleus accumbens feedforward inhibition circuit promotes cocaine self-administration |
| Q34614351 | Presynaptic long-term depression mediated by Gi/o-coupled receptors. |
| Q35499568 | Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection |
| Q39381131 | Synaptic functions of endocannabinoid signaling in health and disease |
Search more.